Anacor Pharma Reports Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Conferences

By: via Benzinga
Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) announced today that data from the Phase 3 pivotal studies of investigational drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.